These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9690571

  • 41. Short-term treatment with a low dose of inhaled fluticasone propionate decreases the number of CD1a+ dendritic cells in asthmatic airways.
    Bocchino V, Bertorelli G, Zhuo X, Grima P, Di Comite V, Damia R, Chetta A, Del Donno M, Foresi A, Casalini A, Testi R, Olivieri D.
    Pulm Pharmacol Ther; 1997; 10(5-6):253-9. PubMed ID: 9778488
    [Abstract] [Full Text] [Related]

  • 42. Steroid-resistant asthma: evaluation and management.
    Nimmagadda SR, Spahn JD, Leung DY, Szefler SJ.
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):345-55; quiz 355-6. PubMed ID: 8933772
    [Abstract] [Full Text] [Related]

  • 43. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
    Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A.
    N Engl J Med; 2018 Jun 28; 378(26):2475-2485. PubMed ID: 29782224
    [Abstract] [Full Text] [Related]

  • 44. [Effect of glucocorticoid on CD4 T-lymphocyte and eosinophil activation in asthmatics].
    Deng H, Sun B.
    Zhonghua Nei Ke Za Zhi; 1997 Jun 28; 36(1):7-10. PubMed ID: 9812552
    [Abstract] [Full Text] [Related]

  • 45. Heat shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids.
    Bertorelli G, Bocchino V, Zhuo X, Chetta A, Del Donno M, Foresi A, Testi R, Olivieri D.
    Clin Exp Allergy; 1998 May 28; 28(5):551-60. PubMed ID: 9645591
    [Abstract] [Full Text] [Related]

  • 46. Improvement in health care utilization and pulmonary function with fluticasone propionate in patients with steroid-dependent asthma at a National Asthma Referral Center.
    Wenzel SE, Morgan K, Griffin R, Stanford R, Edwards L, Wamboldt FS, Rogenes P.
    J Asthma; 2001 Aug 28; 38(5):405-12. PubMed ID: 11515977
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
    Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID, SIRIUS Investigators.
    N Engl J Med; 2014 Sep 25; 371(13):1189-97. PubMed ID: 25199060
    [Abstract] [Full Text] [Related]

  • 49. Serum eosinophil cationic protein for predicting the prognosis of a step-down in inhaled corticosteroid therapy in adult chronic asthmatics.
    Baba K, Hattori T, Koishikawa I, Yoshida K, Kobayashi T, Takagi K.
    J Asthma; 2000 Aug 25; 37(5):399-408. PubMed ID: 10983617
    [Abstract] [Full Text] [Related]

  • 50. Effect of fluticasone propionate on interleukin-12 and interferon-gamma production in patients affected by allergic bronchial asthma.
    Purello-D'Ambrosio F, Gangemi S, Merendino RA, Arena A, Guarneri F, Ricciardi L.
    J Investig Allergol Clin Immunol; 1999 Aug 25; 9(4):262-7. PubMed ID: 10513354
    [Abstract] [Full Text] [Related]

  • 51. Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study.
    Baraket M, Oliver BG, Burgess JK, Lim S, King GG, Black JL.
    Respir Res; 2012 Feb 02; 13(1):11. PubMed ID: 22300506
    [Abstract] [Full Text] [Related]

  • 52. Development of fluticasone propionate and comparison with other inhaled corticosteroids.
    Johnson M.
    J Allergy Clin Immunol; 1998 Apr 02; 101(4 Pt 2):S434-9. PubMed ID: 9563368
    [Abstract] [Full Text] [Related]

  • 53. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study.
    Decco ML, Neeno TA, Hunt LW, O'Connell EJ, Yunginger JW, Sachs MI.
    Ann Allergy Asthma Immunol; 1999 Jan 02; 82(1):29-32. PubMed ID: 9988203
    [Abstract] [Full Text] [Related]

  • 54. Fluticasone propionate--an update on preclinical and clinical experience.
    Fuller R, Johnson M, Bye A.
    Respir Med; 1995 Sep 02; 89 Suppl A():3-18. PubMed ID: 7569173
    [Abstract] [Full Text] [Related]

  • 55. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma.
    Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos GP, Szefler SJ, Leung DY.
    Am J Respir Crit Care Med; 1999 May 02; 159(5 Pt 1):1600-4. PubMed ID: 10228133
    [Abstract] [Full Text] [Related]

  • 56. Role of the indoor environment in determining the severity of asthma.
    Woodcock A, Custovic A.
    Thorax; 1998 Aug 02; 53 Suppl 2(Suppl 2):S47-51. PubMed ID: 10193348
    [Abstract] [Full Text] [Related]

  • 57. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
    Corrigan CJ, Bungre JK, Assoufi B, Cooper AE, Seddon H, Kay AB.
    Eur Respir J; 1996 Oct 02; 9(10):2077-86. PubMed ID: 8902470
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.